C. Giannesini

1.8k total citations
15 papers, 927 citations indexed

About

C. Giannesini is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Giannesini has authored 15 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pathology and Forensic Medicine, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Giannesini's work include Multiple Sclerosis Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Neurological Disease Mechanisms and Treatments (2 papers). C. Giannesini is often cited by papers focused on Multiple Sclerosis Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and Neurological Disease Mechanisms and Treatments (2 papers). C. Giannesini collaborates with scholars based in France, Algeria and Australia. C. Giannesini's co-authors include Mathieu Zuber, Jean‐Louis Mas, Caroline Arquizan, Catherine Lamy, Jean-François Méder, Joël Coste, D. Trystram, Bruno Stankoff, Caroline Papeix and Céline Louapre and has published in prestigious journals such as Stroke, Journal of Virology and Brain Behavior and Immunity.

In The Last Decade

C. Giannesini

15 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Giannesini France 10 374 342 288 256 140 15 927
Christopher Allen United Kingdom 12 341 0.9× 166 0.5× 164 0.6× 66 0.3× 345 2.5× 35 821
Paolo Immovilli Italy 13 376 1.0× 85 0.2× 378 1.3× 392 1.5× 80 0.6× 44 837
James Overell United Kingdom 12 618 1.7× 658 1.9× 223 0.8× 29 0.1× 328 2.3× 28 1.3k
Maria Lopez-Bresnahan United States 13 214 0.6× 95 0.3× 418 1.5× 42 0.2× 82 0.6× 15 692
Nizar Souayah United States 17 486 1.3× 44 0.1× 62 0.2× 124 0.5× 139 1.0× 105 948
Luciana Porto Germany 16 160 0.4× 149 0.4× 44 0.2× 74 0.3× 164 1.2× 58 706
James B Lilleker United Kingdom 20 292 0.8× 63 0.2× 78 0.3× 124 0.5× 656 4.7× 77 1.1k
Alex Rae-Grant United States 11 378 1.0× 103 0.3× 169 0.6× 33 0.1× 81 0.6× 17 591
Alan McDougall Australia 17 178 0.5× 74 0.2× 231 0.8× 17 0.1× 193 1.4× 41 724
Chiara Bellocchi Italy 14 57 0.2× 75 0.2× 245 0.9× 82 0.3× 78 0.6× 43 643

Countries citing papers authored by C. Giannesini

Since Specialization
Citations

This map shows the geographic impact of C. Giannesini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Giannesini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Giannesini more than expected).

Fields of papers citing papers by C. Giannesini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Giannesini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Giannesini. The network helps show where C. Giannesini may publish in the future.

Co-authorship network of co-authors of C. Giannesini

This figure shows the co-authorship network connecting the top 25 collaborators of C. Giannesini. A scholar is included among the top collaborators of C. Giannesini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Giannesini. C. Giannesini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Louapre, Céline, Nicolas Collongues, Bruno Stankoff, et al.. (2020). Clinical characteristics and outcomes in patients with coronavirus disease 2019 and multiple sclerosis. Multiple Sclerosis Journal. 26. 49–50. 84 indexed citations
2.
Ouallet, Jean‐Christophe, Françoise Radat, Alain Créange, et al.. (2020). Evaluation of emotional disorders before and during treatment with interferon beta in patients with multiple sclerosis. Journal of the Neurological Sciences. 413. 116739–116739. 6 indexed citations
3.
Louapre, Céline, Nicolas Collongues, Bruno Stankoff, et al.. (2020). Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis. JAMA Neurology. 77(9). 1079–1079. 287 indexed citations
4.
Poittevin, Marine, et al.. (2019). Glatiramer acetate reduces infarct volume in diabetic mice with cerebral ischemia and prevents long-term memory loss. Brain Behavior and Immunity. 80. 315–327. 19 indexed citations
5.
Monfort, J.‐B., C. Giannesini, P. Duriez, et al.. (2018). Lymphoprolifération cutanée primitive CD30+ sous fingolimod : un cas et revue systématique de la littérature. Annales de Dermatologie et de Vénéréologie. 145(6-7). 433–438. 4 indexed citations
6.
Bottin, Laure, Stéphanie Guey, C. Giannesini, et al.. (2015). Biotinidase deficiency mimicking neuromyelitis optica: Initially exhibiting symptoms in adulthood. Multiple Sclerosis Journal. 21(12). 1604–1607. 42 indexed citations
7.
Hendel-Chavez, Houria, Marie-Ghislaine de Goër de Herve, C. Giannesini, et al.. (2013). Immunological Hallmarks of JC Virus Replication in Multiple Sclerosis Patients on Long-Term Natalizumab Therapy. Journal of Virology. 87(10). 6055–6059. 21 indexed citations
8.
Poittevin, Marine, Nicolas Deroide, Fériel Azibani, et al.. (2012). Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice. Journal of Neuroimmunology. 254(1-2). 55–62. 28 indexed citations
9.
Lescure, François‐Xavier, et al.. (2012). Paraplégie flasque due à des abcès intramédullaires et épiduraux à staphylocoques dorés. Méningite et spondylodiscite associées. Revue Neurologique. 168(11). 868–872. 5 indexed citations
10.
Nataf, V., Khaldoun Kerrou, Soňa Balogová, et al.. (2010). TEP à la fluoroéthyltyrosine (18F) pour la détection des tumeurs cérébrales. Bulletin du Cancer. 97(5). 495–506. 1 indexed citations
11.
Faugère, Valérie, David Baux, C. Giannesini, et al.. (2009). Molecular screening of deafness in Algeria: High genetic heterogeneity involving DFNB1 and the Usher loci, DFNB2/USH1B, DFNB12/USH1D and DFNB23/USH1F. European Journal of Medical Genetics. 52(4). 174–179. 25 indexed citations
12.
Clarençon, Frédéric, C. Giannesini, A. Pénicaud, et al.. (2008). MRI and FDG PET/CT findings in a case of probable Heidenhain variant Creutzfeldt-Jakob disease. Journal of Neuroradiology. 35(4). 240–243. 14 indexed citations
13.
Bonnin, Philippe, et al.. (2003). Doppler sonograpy with dynamic testing in a case of aortic dissection extending to the innominate and right common carotid arteries. Neuroradiology. 45(7). 472–475. 6 indexed citations
14.
Lamy, Catherine, C. Giannesini, Mathieu Zuber, et al.. (2002). Clinical and Imaging Findings in Cryptogenic Stroke Patients With and Without Patent Foramen Ovale. Stroke. 33(3). 706–711. 354 indexed citations
15.
Giannesini, C., et al.. (1999). Cardiac Papillary Fibroelastoma:A Rare Cause of Isch emic Stroke in the Young. Cerebrovascular Diseases. 9(1). 45–49. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026